CLN3 and juvenile neuronal ceroid lipofuscinosis: The detection of DNA damage markers downstream of impairment of lysosomal phospholipid catabolism opens the possibility for novel disease-modifying therapeutic strategies for patients with Batten disease caused by mutations in CLN3.